Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.57 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.57 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.43 |
| ▸ | TUBB | P07437 | 1/20 | 0.43 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.43 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.43 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.43 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.43 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.43 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.43 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.43 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.43 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.43 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.43 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.43 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.43 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28168668 | 0.98 | CYP2A6 (0.55) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| Iodoform SCHEMBL28508578 | 0.93 | CYP2A6 (0.50) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL10923774 | 0.83 | AHR (0.50) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL18420127 | 0.81 | TUBB4A (0.45) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL12402939 | 0.81 | TUBB4A (0.45) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| Valine SCHEMBL5651474 | 0.80 | SLC7A5 (0.40) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL5437029 | 0.79 | AHR (0.50) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL8051282 | 0.79 | AHR (0.50) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL22925047 | 0.79 | AHR (0.50) | CYP2A6IMPDH2AHRTUBB4ATUBB | |
| SCHEMBL10720454 | 0.79 | AHR (0.46) | CYP2A6IMPDH2AHRTUBB4ATUBB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 904 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117723688-B | Pretreatment method and detection method for indole substances in aquatic products | 浙江省食品药品检验研究院 | 2026-05-12 | — | — | CN | claimed |
| EP-4709401-A1 | ORAL DELIVERY OF PLANT DERIVED VESICLES AND USES THEREOF | Board of Regents, The University of Texas System (US) | 2026-03-18 | — | — | EP | claimed |
| EP-4704837-A2 | METHODS FOR USING BACTERIA AND HOST/MICROBIOTA-DERIVED METABOLITES FOR DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS | Baylor College of Medicine (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| CN-119780269-A | Method for discovering cough relieving and phlegm eliminating quality markers of Kening granules and quality markers | 贵州大隆药业有限责任公司 | 2025-04-08 | — | — | CN | claimed |
| CN-118549543-B | Multicomponent foreign matter for detecting authenticity of betel nut honey as well as acquisition method and application thereof | 中国农业科学院蜜蜂研究所 | 2025-01-24 | — | — | CN | claimed |
| WO-2024233935-A1 | ORAL DELIVERY OF PLANT DERIVED VESICLES AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024233382-A2 | METHODS FOR USING BACTERIA AND HOST/MICROBIOTA-DERIVED METABOLITES FOR DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS | BAYLOR COLLEGE OF MEDICINE (US) | 2024-11-14 | — | — | WO | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| CN-118549543-A | Multicomponent foreign matter for detecting authenticity of betel nut honey as well as acquisition method and application thereof | 中国农业科学院蜜蜂研究所 | 2024-08-27 | — | — | CN | claimed |
| CN-102351774-B | Preparation method for indole-4-formaldehyde | CHANGZHOU SUNLIGHT PHARM CO LTD | 2014-03-26 | — | — | CN | claimed |
| CN-102351774-A | Preparation method for indole-4-formaldehyde | CHANGZHOU SUNLIGHT PHARM CO LTD | 2012-02-15 | — | — | CN | claimed |
| CN-101245045-A | Process for synthesizing indole-4-methanal | UNIV SOUTHEAST (CN) | 2008-08-20 | — | — | CN | claimed |
| US-20040014796-A1 | Novel compounds and compositions as cathepsin S inhititors | AXYS PHARMACEUTICALS, INC. | 2004-01-22 | — | — | US | claimed |
| EP-1212302-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2002-06-12 | — | — | EP | claimed |
| WO-2001019796-A1 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS | AXYS PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| EP-0395528-B1 | 4-Phenylmethyl-1H-indole derivatives, process and intermediates for their preparation, their use as medicines and compositions containing them | ROUSSEL UCLAF (FR) | 1995-07-05 | — | — | EP | claimed |
| EP-0395528-A2 | 4-Phenylmethyl-1H-indole derivatives, process and intermediates for their preparation, their use as medicines and compositions containing them | ROUSSEL-UCLAF (FR) | 1990-10-31 | — | — | EP | claimed |
| EP-0150139-B1 | INDOLE-ETHYLPHENOL DERIVATIVES, THEIR SALTS, PROCESS FOR THEIR PEPARATION, THEIR USES AS MEDICINES AND COMPOSITIONS CONTAINING THEM | ROUSSEL-UCLAF (FR) | 1988-05-18 | — | — | EP | claimed |
| EP-0150139-A2 | Indole-ethylphenol derivatives, their salts, process for their peparation, their uses as medicines and compositions containing them | ROUSSEL-UCLAF (FR) | 1985-07-31 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040014796-A1 | Novel compounds and compositions as cathepsin S inhititors | CTSS, CTSB, CTSE | CYP2A6 2616/4885IMPDH2 3126/4885AHR 3382/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.